Yi-Ting Chen

Dr. Yi-Ting Chen

Kaohsiung Medical University, Kaohsiung City, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2016 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
TZE-KIONG ERTZE-KIONG ER
TZE-KIONG ER
YSYu-Fa Su
Yu-Fa Su
CWChun-Chieh Wu
Chun-Chieh Wu
CCChih-Chieh Chen
Chih-Chieh Chen
JWJing Wang
Jing Wang
ETEing Mei Tsai
Eing Mei Tsai

13 December 2013 in BMC Cancer
Verified
Journal Article
Open access
PDF file
CHChing-Wen Huang
Ching-Wen Huang
HTHsiang-Lin Tsai
Hsiang-Lin Tsai
YCYi-Ting Chen
Yi-Ting Chen
CHChun-Ming Huang
Chun-Ming Huang
CMCheng-Jen Ma
Cheng-Jen Ma
Jaw-Yuan WangJaw-Yuan Wang
Jaw-Yuan Wang
The epidermal growth factor receptor (EGFR)/RAS/RAF/MEK/MAPK pathway is an important pathway in the carcinogenesis, invasion and metastasis of colorectal cancers (CRCs). We conducted a retrospective study to determine the prognostic values of EGFR expression and KRAS mutation in patients with metastatic CRC (mCRC) based on synchronous or metachronous status. From October 2002 to March 2012, 205 patients with mCRC were retrospectively analyzed; 98 were found to have metachronous mCRC while 107 were found to have synchronous mCRC. The EGFR expressions were determinate by IHC (immunohistochemistry) analysis and categorized 1+ (weak intensity), 2+ (moderate intensity), and 3+ (strong intensity). Genomic DNA was isolated from frozen primary CRC tissues and direct sequencing of KRAS was performed. The clinicopathological features of these mCRC patients were retrospectively investigated according to EGFR expression and KRAS mutation status. Moreover, we analyzed the prognostic values of EGFR expression and KRAS mutation among these patients. Of the 205 patients with mCRC, EGFR expression was analyzed in 167 patients, and positive EGFR expression was noted in 140 of those patients (83.8%). KRAS mutation was investigated in 205 patients and mutations were noted in 88 of those patients (42.9%). In patients with metachronous mCRC, positive EGFR expression was significantly correlated with well-and moderately-differentiated tumors (P = 0.028), poorer disease-free survival (DFS) (P < 0.001), and overall survival (OS) (P < 0.001). Furthermore, positive EGFR expression was a significant independent prognostic factor of DFS (P = 0.006, HR: 4.012, 95% CI: 1.130–8.445) and OS (P = 0.028, HR: 3.090, 95% CI: 1.477–10.900) in metachronous mCRC patients. KRAS mutation status was not significantly related to DFS and OS of patients with metachronous mCRC; likewise, KRAS mutation status was not significantly different in the progression-free survival (PFS) and OS of patients with synchronous mCRC (all P > 0.05). The present study demonstrated that EGFR expression has prognostic value only for patients with metachronous mCRC. However, KRAS mutation did not have prognostic value in patients with metachronous or synchronous mCRC.

23 August 2017 in Stem Cells
Verified
Journal Article
Open access
PDF file
DWDeng-Chyang Wu
Deng-Chyang Wu
SWSophie S.W. Wang
Sophie S.W. Wang
CLChung-Jung Liu
Chung-Jung Liu
KWKenly Wuputra
Kenly Wuputra
KKKohsuke Kato
Kohsuke Kato
Kazunari K. YokoyamaKazunari K. Yokoyama
Kazunari K. Yokoyama
Reprogramming of cancer cells into induced pluripotent stem cells (iPSCs) is a compelling idea for inhibiting oncogenesis, especially through modulation of homeobox proteins in this reprogramming process. We examined the role of various long noncoding RNAs (lncRNAs)-homeobox protein HOXA13 axis on the switching of the oncogenic function of bone morphogenetic protein 7 (BMP7), which is significantly lost in the gastric cancer cell derived iPS-like cells (iPSLCs). BMP7 promoter activation occurred through the corecruitment of HOXA13, mixed-lineage leukemia 1 lysine N-methyltransferase, WD repeat-containing protein 5, and lncRNA HoxA transcript at the distal tip (HOTTIP) to commit the epigenetic changes to the trimethylation of lysine 4 on histone H3 in cancer cells. By contrast, HOXA13 inhibited BMP7 expression in iPSLCs via the corecruitment of HOXA13, enhancer of zeste homolog 2, Jumonji and AT rich interactive domain 2, and lncRNA HoxA transcript antisense RNA (HOTAIR) to various cis-element of the BMP7 promoter. Knockdown experiments demonstrated that HOTTIP contributed positively, but HOTAIR regulated negatively to HOXA13-mediated BMP7 expression in cancer cells and iPSLCs, respectively. These findings indicate that the recruitment of HOXA13–HOTTIP and HOXA13–HOTAIR to different sites in the BMP7 promoter is crucial for the oncogenic fate of human gastric cells. Reprogramming with octamer-binding protein 4 and Jun dimerization protein 2 can inhibit tumorigenesis by switching off BMP7.

9 December 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
CHChing-Wen Huang
Ching-Wen Huang
YCYi-Ting Chen
Yi-Ting Chen
HTHsiang-Lin Tsai
Hsiang-Lin Tsai
YYYung-Sung Yeh
Yung-Sung Yeh
WSWei-Chih Su
Wei-Chih Su
Jaw-Yuan WangJaw-Yuan Wang
Jaw-Yuan Wang
EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function

7 March 2012 in BMC Public Health
Verified
Journal Article
Open access
PDF file
WTWei Chung Tsai
Wei Chung Tsai
MWMing-Tsang Wu
Ming-Tsang Wu
GWGuei-Jane Wang
Guei-Jane Wang
KLKun-Tai Lee
Kun-Tai Lee
CLChien-Hung Lee
Chien-Hung Lee
WLWen-Ter Lai
Wen-Ter Lai
Background: Areca nut chewing has been reported to be associated with obesity, metabolic syndrome, hypertension, and cardiovascular mortality in previous studies. The aim of this study was to examine whether chewing areca nut increases the risk of coronary artery disease (CAD) in Taiwanese men. Methods: This study is a hospital-based case-control study. The case patients were male patients diagnosed in Taiwan between 1996 and 2009 as having a positive Treadmill exercise test or a positive finding on the Thallium-201 single-photon emission computed tomography myocardial perfusion imaging. The case patients were further evaluated by coronary angiography to confirm their CAD. Obstructive CAD was defined as a ≥ 50% decrease in the luminal diameter of one major coronary artery. The patients who did not fulfill the above criteria of obstructive CAD were excluded. The potential controls were males who visited the same hospital for health check-ups and had a normal electrocardiogram but no history of ischemic heart disease or CAD during the time period that the case patients were diagnosed. The eligible controls were randomly selected and frequency-matched with the case patients based on age. Multiple logistic regression analyses were used to estimate the odds ratio of areca nut chewing and the risk of obstructive CAD. Results: A total of 293 obstructive CAD patients and 720 healthy controls, all men, were analyzed. Subjects who chewed areca nut had a 3.5-fold increased risk (95% CI = 2.0-6.2) of having obstructive CAD than those without, after adjusting for other significant covariates. The dose-response relationship of chewing areca nut and the risk of obstructive CAD was also noted. After adjusting for other covariates, the 2-way additive interactions for obstructive CAD risk were also significant between areca nut use and cigarette smoking, hypertension and dyslipidemia. Conclusions: Long-term areca nut chewing was an independent risk factor of obstructive CAD in Taiwanese men. Interactive effects between chewing areca nut and cigarette smoking, hypertension, and dyslipidemia were also observed for CAD risk. Further exploration of their underlying mechanisms is necessary.

29 April 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
SWSophie Sw Wang
Sophie Sw Wang
KWKenly Wuputra
Kenly Wuputra
CLChung-Jung Liu
Chung-Jung Liu
YLYin-Chu Lin
Yin-Chu Lin
YCYi-Ting Chen
Yi-Ting Chen
Kazunari K. YokoyamaKazunari K. Yokoyama
Kazunari K. Yokoyama
Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer